STOCKS & COMMODITIES magazine. The Traders' Magazine

Technical Analysis of STOCKS & COMMODITIES
The Traders’ Magazine since 1982
has had over 1,226,237 subscribers from 174 different countries.
37,000 Page Traders’ Archive for $89.99


Article Archive For Keyword: AGONISTES by

  • SWEENEY AGONISTES by John Sweeney

    ARTICLE SYNOPSIS...SWEENEY AGONISTES by John Sweeney I must start off this issue with an apology. In the November 1986 issue, Frank Tarkany published evidence of non-randomness and serial dependence in Dow Jones prices. The Figure 7 we published, which estimated the tradi

  • SWEENEY AGONISTES by John Sweeney

    ARTICLE SYNOPSIS...SWEENEY AGONISTES by John Sweeney OUR APPROACH - Believe it or not, there is method to our madness in publishing articles. Two series of articles going on right now are laying the groundwork for much more rigorous technical systems. Clifford Sherry's a

  • Sweeney Agonistes by John Sweeney

    ARTICLE SYNOPSIS...Sweeney Agonistes by John Sweeney FEEDING FRENZY I opened my Journal today to find Kidder Peabody explaining ""What is a stock?"" on the editorial pages. My mother calls to find out if she should be going for ""higher returns in the market."" I've not

  • Sweeney Agonistes by Technical Analysis, Inc.

    ARTICLE SYNOPSIS...Sweeney Agonistes by Technical Analysis, Inc. KNOW YOUR TIME-HORIZONS My Club 3000 buddies and subscribers often ask how I go about trading. The truth is I use only moving averages and RSI. These are both ""optimized"" with time-horizons approximating






S&C Subscription/Renewal




Request Information From Our Sponsors 

DEPARTMENTS: Advertising | Editorial | Circulation | Contact Us | BY PHONE: (206) 938-0570

PTSK — The Professional Traders' Starter Kit
Home — S&C Magazine | Working Money Magazine | Traders.com Advantage | Online Store | Traders’ Resource
Add a Product to Traders’ Resource | Message Boards | Subscribe/Renew | Free Trial Issue | Article Code | Search

Copyright © 1982–2024 Technical Analysis, Inc. All rights reserved. Read our disclaimer & privacy statement.